<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02677753</url>
  </required_header>
  <id_info>
    <org_study_id>15.0034</org_study_id>
    <nct_id>NCT02677753</nct_id>
  </id_info>
  <brief_title>Percutaneous Nerve Evaluation With Fluoroscopy Versus Without</brief_title>
  <official_title>InterStim Implantation Rates Following Percutaneous Nerve Evaluation With Fluoroscopy Versus Without</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a randomized control trial comparing the rate of implantation of
      the InterStim device following Percutaneous Nerve Evaluation (PNE) performed with or without
      fluoroscopic guidance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sacral nerve stimulation (SNS) is a well-established treatment for refractory urinary
      urgency, frequency, retention and urge incontinence as well as fecal incontinence. Patients
      whose symptoms are refractory to more conservative therapies such as behavioral modification
      and/or medications are candidates for SNS. The InterStim system consists of a permanent tined
      lead and implantable pulse generator (IPG) or battery that delivers the sacral
      neuromodulation. This device is typically implanted after patients have a successful response
      to a trial of sacral neuromodulation with a temporary lead and external battery. The
      temporary lead placement is known as a Percutaneous Nerve Evaluation (PNE) and is typically
      done in as an outpatient procedure using local anesthetic. It is standard practice to use
      fluoroscopy intraoperatively to confirm correct placement of the permanent lead.
      Additionally, some physicians also use fluoroscopy to confirm correct placement of temporary
      lead during PNE while others place the lead based on anatomical landmarks and expected
      elicited responses for S3 stimulation.

      The investigators propose a randomized control trial comparing the rate of implantation of
      the InterStim device following (PNE) performed with or without fluoroscopic guidance.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With InterStim Implantation Following PNE With or Without Use of Fluoroscopy</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage of PNEs that have permanent neuromodulation device implanted by 3 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Overactive Bladder</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Fecal Incontinence</condition>
  <arm_group>
    <arm_group_label>Fluoroscopy guided PNE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluoroscopy will be utilized to assist with placement and/or confirm correct placement of lead wires.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PNE without fluoroscopic guidance</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No fluoroscopy will be used during or after the placement of the lead wires.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Fluoroscopy</intervention_name>
    <arm_group_label>Fluoroscopy guided PNE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women age &gt;18

          -  English speakers

          -  Patients with urinary urgency, frequency, or urge incontinence refractory to at least
             1 other intervention who elect to undergo PNE

        Exclusion Criteria:

          -  Patients in whom bilateral leads cannot be placed

          -  Pregnant women

          -  Prisoners

          -  Less than 18 years of age
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sean L Francis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville Physicians</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 4, 2016</study_first_submitted>
  <study_first_submitted_qc>February 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2016</study_first_posted>
  <results_first_submitted>May 13, 2020</results_first_submitted>
  <results_first_submitted_qc>June 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 9, 2020</results_first_posted>
  <last_update_submitted>June 7, 2020</last_update_submitted>
  <last_update_submitted_qc>June 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Sean Francis</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Age
Race
BMI
Preoperative diagnosis
Previous treatments for urinary urgency, frequency, retention, and/or urinary or fecal incontinence
Percent improvement in symptoms as determined by pre and post PNE voiding diaries
Whether or not InterStim implanted within 3 months of PNE
Date of PNE</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 7, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/53/NCT02677753/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 28, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/53/NCT02677753/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fluoroscopy Guided PNE</title>
          <description>Fluoroscopy will be utilized to assist with placement and/or confirm correct placement of lead wires.
Fluoroscopy</description>
        </group>
        <group group_id="P2">
          <title>PNE Without Fluoroscopic Guidance</title>
          <description>No fluoroscopy will be used during or after the placement of the lead wires.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fluoroscopy Guided PNE</title>
          <description>Fluoroscopy will be utilized to assist with placement and/or confirm correct placement of lead wires.
Fluoroscopy</description>
        </group>
        <group group_id="B2">
          <title>PNE Without Fluoroscopic Guidance</title>
          <description>No fluoroscopy will be used during or after the placement of the lead wires.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="74"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.94" spread="14.29"/>
                    <measurement group_id="B2" value="57.84" spread="14.01"/>
                    <measurement group_id="B3" value="57.89" spread="14.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Indication for PNE, Urge urinary incontinence</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With InterStim Implantation Following PNE With or Without Use of Fluoroscopy</title>
        <description>Percentage of PNEs that have permanent neuromodulation device implanted by 3 months</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fluoroscopy Guided PNE</title>
            <description>Fluoroscopy will be utilized to assist with placement and/or confirm correct placement of lead wires.
Fluoroscopy</description>
          </group>
          <group group_id="O2">
            <title>PNE Without Fluoroscopic Guidance</title>
            <description>No fluoroscopy will be used during or after the placement of the lead wires.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With InterStim Implantation Following PNE With or Without Use of Fluoroscopy</title>
          <description>Percentage of PNEs that have permanent neuromodulation device implanted by 3 months</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Within 3 months after PNE placement</time_frame>
      <desc>Patients were queried at time of procedure as well as post op and adverse events were recorded. The PI also reviewed the charts at completion of study and collected any additional adverse event data</desc>
      <group_list>
        <group group_id="E1">
          <title>Fluoroscopy Guided PNE</title>
          <description>Fluoroscopy will be utilized to assist with placement and/or confirm correct placement of lead wires.
Fluoroscopy</description>
        </group>
        <group group_id="E2">
          <title>PNE Without Fluoroscopic Guidance</title>
          <description>No fluoroscopy will be used during or after the placement of the lead wires.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Pain, premature of retained lead</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="36"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There were no sponsors for this study</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Sean Francis</name_or_title>
      <organization>University of Louisville</organization>
      <phone>5025617260</phone>
      <email>sean.francis@louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

